Exeltis' Slynd

Facebook post lands Exeltis in hot water

Women's health pharma Exeltis USA has been reprimanded by the FDA for making a Facebook post that promoted its birth control product Slynd, overstating its efficacy and fa

Perrigo's Opill

OTC birth control arrives in the US

The first-ever over-the-counter contraceptive pill has finally been approved for sale in the US, extending the choice of birth control options available to women.


FDA advisors backs first OTC contraceptive

An FDA advisory committee has unanimously voted in favour of approval for what could become the first oral contraceptive to be made available in the US without a doctor’s